Board Meeting20 Jul 2026, 12:34 pm
Piramal Pharma Board Meeting on July 29, 2026 for Unaudited Results
AI Summary
Piramal Pharma Ltd has announced that its Board of Directors will convene on July 29, 2026. The primary agenda for this meeting is to consider and approve the Unaudited Financial Results for the quarter ending June 30, 2026, covering both standalone and consolidated statements. Additionally, the company has informed that the trading window for its securities will remain closed from July 1, 2026, until July 31, 2026, inclusive, in compliance with SEBI Listing Regulations.
Key Highlights
- Board meeting scheduled for July 29, 2026.
- To approve Unaudited Financial Results for Q1 FY27.
- Results will be standalone and consolidated.
- Trading window closed from July 1 to July 31, 2026.
Price Impact
More from PPLPHARMA